Abstract
Background
Anxiety and depression are common entities in patients diagnosed with COPD. However, the impact that they have on the exacerbation of illness is scarcely studied.
Objective
To determine if the presence of anxiety and depression is associated with a greater risk of frequent exacerbation (≥2 per year) in patients diagnosed with COPD.
Patients and Methods
A cohort study that analysed frequent exacerbation and associated factors in 512 patients monitored during 2 years. Exacerbations were defined as events that required antibiotic/s and/or systemic corticosteroids (moderate) or hospitalization (serious). Variables of interest were recorded for each patient, including anxiety and depression (Hospital Anxiety and Depression Scale), and we analysed their association with frequent exacerbation through the adjusted odds ratio (aOR) by means of a logistic regression model.
Results
The prevalence of anxiety/depression at the start of the study was of 15.6%. During the 2 years of monitoring, 77.9% of the patients suffered at least moderate-to-severe exacerbation. 54.1% were frequent exacerbators. Anxiety/depression were strongly associated with moderate–severe frequent exacerbation in the crude analysis (ORc = 2.28). In the multivariate analysis, the risk factors also associated with frequent exacerbation were being overweight (aOR 2.78); obesity (aOR 3.02); diabetes (aOR 2.56) and the associated comorbidity (BODEx) (ORa = 1.45).
Conclusions
The prevalence of anxiety/depression in COPD patients is high, and they are relevant risk factors in frequent exacerbation although the effect is lower in the multivariate analysis when adjusting for different variables strongly associated with exacerbation.
Similar content being viewed by others
References
Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G et al (2009) Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64(10):863–868
Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(5 Pt 1):1418–1422
Husebø GR, Bakke PS, Aanerud M, Hardie JA, Ueland T, Grønseth R et al (2014) Predictors of exacerbations in chronic obstructive pulmonary disease-results from the Bergen COPD cohort study. PLoS ONE 9(10):e109721
Müllerová H, Shukla A, Hawkins A, Quint J (2014) Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open 4:e006171
Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57(10):847–852
Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS et al (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23(6):932–946
Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP et al (2005) Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 127(4):1205–1211
Calle M, Rodriguez JL, Gomez MJ (2009) Ansiedad y EPOC. Arch Bronconeumol 45(4):51–53
Jennings JH, Digiovine B, Obeid D, Frank C (2009) The association between depressive symptoms and acute exacerbations of COPD. Lung 187(2):128–135
Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58(2):100–105
Peruzza S, Sergi G, Vianello A, Pisent C, Tiozzo F, Manzan A et al (2003) Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. Respir Med 97(6):612–617
Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A (2003) A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 25(4):277–283
Global Initiative for Chronic Obstructive Pulmonary Disease GOLD (2014) Global strategy for diagnosis, management and prevention of COPD. Pulm Pharmacol Ther 29:144
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555
Jones PW, Harding G, Berry P, Wiklund I, Chen WHKLN (2009) Development and first validation of the COPD assessment test. Respir J 34:648–654
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586
Soler-Cataluña JJ, Martínez-García MA, Sánchez LS, Tordera MP, Sánchez PR (2009) Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 103(5):692–699
Simon GEVKM (2006) Medical co-morbidity and validity of DSM-IV depression criteria. Psychol Med 36(1):27–36
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370
Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128–1138
Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370(9589):786–796
Xu W, Collet J-P, Shapiro S, Lin Y, Yang T, Platt RW et al (2008) Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 178(9):913–920
Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS et al (2005) Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 26(3):414–419
Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ (2010) Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry 25(12):1209–1221
Burge S, Wedzicha JA (2003) COPD exacerbations: definitions and classifications. Eur Respir J Suppl 41:46s–53s
Laurin C, Labrecque M, Dupuis G, Bacon SL, Cartier A, Lavoie KL (2009) Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med 71(6):667–674
Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT et al (2007) Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 167(21):2345–2353
Ng T-P, Niti M, Tan W-C, Cao Z, Ong K-C, Eng P (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167(1):60–67
Bremmer MA, Beekman ATF, Deeg DJH, Penninx BWJH, Dik MG, Hack CE et al (2008) Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106(3):249–255
Cohen S, Tyrrell DA, Smith AP (1993) Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol 64(1):131–140
Laurin C, Moullec G, Bacon SL, Lavoie KL (2012) Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 185(9):918–923
Burgess A, Kunik ME, Stanley MA (2005) Chronic obstructive pulmonary disease: assessing and treating psychological issues in patients with COPD. Geriatrics 60(12):18–21
Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé FGL (2016) Risk factors for exacerbation in chronic obstructive pulmonary disease: a prospective study. Int J Tuberc Lung Dis 20(3):389–395
Almagro P (2007) Factores pronósticos en la EPOC. El papel de la comorbilidad. Rev clínica española 207(1):8–13
Ramsey SD, Hobbs FDR (2006) Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease. Proc Am Thorac Soc 3(7):635–640
Cazzola M, Calzetta L, Rogliani P, Lauro D, Novelli L, Page CP et al (2012) High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. Am J Respir Cell Mol Biol 47(4):509–516
Jordan N, Lee TA, Valenstein M, Weiss KB (2007) Effect of care setting on evidence-based depression treatment for veterans with COPD and comorbid depression. J Gen Intern Med 22(10):1447–1452
Martinez Rivera C, Costan Galicia J, Alcázar Navarrete B, Garcia-Polo C, Ruiz Iturriaga LA, Herrejón A et al (2016) Factors associated with depression in COPD: a multicenter study. Lung 194(3):335–343
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The study was approved by the Clinical Research Ethics Committee of the Primary Care Research Institute (IDIAP) Jordi Gol (P14/022) Barcelona.
Rights and permissions
About this article
Cite this article
Montserrat-Capdevila, J., Godoy, P., Marsal, J.R. et al. Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary Disease. Lung 195, 77–85 (2017). https://doi.org/10.1007/s00408-016-9966-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-016-9966-0